Management of infants on home oxygen

Improvements in survival of premature babies over the last two decades are mainly attributed to the use of antenatal steroids and postnatal surfactant therapy. Despite this reduction in mortality, there has not been an overall reduction in chronic lung disease of prematurity. This article discusses the evidence available and the authors’ experience of managing infants on home oxygen from a tertiary neonatal unit.